SCHEMBL311442

SCHEMBL311442

C[Si](C)(C)c1c(-c2ccccc2)c2cc3nc(cc4ccc(cc5nc(cc1[nH]2)C=C5)[nH]4)C=C3

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.50
▸ STAT1 P42224 1/20 0.50
▸ IRS1 P35568 1/20 0.33
▸ DHODH Q02127 3/20 0.32
▸ GAA P10253 3/20 0.31
▸ MAPT P10636 3/20 0.31
▸ NPC1 O15118 3/20 0.31
▸ RAB9A P51151 3/20 0.31
▸ CHEK1 O14757 1/20 0.31
▸ AKT2 P31751 1/20 0.31
▸ HPGD P15428 4/20 0.31
▸ SMN1; SMN2 Q16637 3/20 0.31
▸ KDM4E B2RXH2 3/20 0.31
▸ ALDH1A1 P00352 3/20 0.31
▸ TP53 P04637 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ NOX1 Q9Y5S8 1/20 0.31
▸ RPS6KA3 P51812 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ NFKB1 P19838 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL226837 0.87 STAT3 (0.59) STAT3STAT1DHODHGAAMAPT
SCHEMBL14054511 0.85 STAT3 (0.57) STAT3STAT1DHODHGAAMAPT
SCHEMBL6265476 0.85 STAT3 (0.57) STAT3STAT1DHODHGAAMAPT
SCHEMBL31499126 0.83 STAT3 (0.52) STAT3STAT1DHODHGAAMAPT
SCHEMBL31279570 0.82 STAT3 (0.51) STAT3STAT1DHODHGAAMAPT
SCHEMBL7762016 0.81 STAT3 (0.54) STAT3STAT1GAAMAPTNPC1
SCHEMBL5013670 0.81 STAT3 (0.54) STAT3STAT1DHODHGAAMAPT
SCHEMBL5067206 0.80 STAT3 (0.52) STAT3STAT1GAAMAPTNPC1
SCHEMBL899162 0.80 STAT3 (0.52) STAT3STAT1DHODHGAAMAPT
SCHEMBL31435711 0.80 STAT3 (0.52) STAT3STAT1GAAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8092661-B2 Electropolymerisable monomers, soluble in an aqueous solution and comprising a metalloporphyrin BIOMERIEUX (FR) 2012-01-10 — — US disclosed
US-20090314660-A1 Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin BIOMERIEUX (FR) 2009-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090314660-A1 Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin EPS15, PPOX, ACR STAT3 492/4885STAT1 1954/4885IRS1 2431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback